Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Soraya Amalí Zavaleta Muñiz"'
Autor:
Claudia Muñoz Yañez, Alejandra Méndez Hernández, Alondra Martínez Sandoval, María Aurora Maravilla Domínguez, Soraya Amalí Zavaleta Muñiz, Janeth Oliva Guangorena Gómez
Publikováno v:
BMC Microbiology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Blastocystis is a typical anaerobic colon protist in humans with controversial pathogenicity and has relation with alterations in the intestinal microbiota composition (dysbiosis), whose eventual indicator is the Firmicutes/Bacter
Externí odkaz:
https://doaj.org/article/db331ca6431941079c62c7aaa52fc09d
Autor:
Valeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 35:53-63
Triglycerides are the initiators of the metabolic changes that lead to atherogenic dyslipidemia (AD). The APOA5 and APOA1 genes are involved in the response and metabolism of serum lipids and lipoproteins, where single nucleotide polymorphisms (SNP)
Autor:
Alondra Martínez-Sandoval, Soraya Amalí Zavaleta-Muñiz, María Aurora Maravilla-Domínguez, Janeth Oliva Guangorena-Gómez, Claudia Muñoz-Yañez, Alejandra Méndez-Hernández
Background: Blastocystis is a typical anaerobic colon protist in humans with controversial pathogenicity and has relation with alterations in the intestinal microbiota composition (dysbiosis), whose indicator is the Firmicutes/Bacteroidetes ratio (F/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a11edfa2e7dd66f0119e021e6b38d7c
https://doi.org/10.21203/rs.3.rs-537437/v1
https://doi.org/10.21203/rs.3.rs-537437/v1
Autor:
María Aurora Maravilla Domínguez, María de Lourdes Zermeño González, Elias Roberto Zavaleta Muñiz, Verónica Adriana Montes Varela, Cesar Antonio Irecta Nájera, Nicté Selene Fajardo Robledo, Soraya Amalí Zavaleta Muñiz
Publikováno v:
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 34(3)
Type two diabetes mellitus (T2DM) is characterized by a chronic inflammation status. Altered markers such as lipid concentrations are usually found in this disease. Elevated inflammation markers have been described such as cytokines (interleukin 6, t
Autor:
Fernanda-Isadora Corona-Meraz, Soraya-Amalí Zavaleta-Muñiz, Beatriz Teresita Martín-Márquez, Ana-Lilia Fletes-Rayas, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, Erika-Aurora Martínez-García
Publikováno v:
Nutrición Hospitalaria v.38 n.4 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Banco de España
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Banco de España
Background: type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia, insulin resistance (IR), and abnormal fatty acid metabolism in which the CD36 receptor has been implicated in glucose and lipid dysregulation.